8-KOther EventsExhibits & Filings

Baker Hughes Co 8-K Report, Corporate Update (Nov 7, 2025)

Filed November 7, 2025For Securities:BKR

Summary

This 8-K filing from Baker Hughes Co. (BKR) announces a significant development in their previously announced acquisition of Chart Industries, Inc. (Chart). The key update is the expiration of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act (HSR Act), which is a crucial regulatory step towards completing the merger. While this hurdle has been cleared, the transaction is still subject to other customary conditions and regulatory approvals, with the expected closing timeline remaining mid-year 2026. Investors should note that the completion of this acquisition remains contingent on several factors, including obtaining all necessary regulatory approvals and Baker Hughes's ability to manage the substantial debt it expects to incur. The company also cautions that actual results could differ materially from forward-looking statements due to various risks, including integration challenges, competition, and general economic conditions. The filing serves as an important update on the progress and ongoing complexities of this significant strategic transaction.

Key Highlights

  • 1Expiration of Hart-Scott-Rodino (HSR) Act waiting period for the Chart Industries acquisition, a key regulatory milestone.
  • 2The merger with Chart Industries is still expected to close in mid-year 2026.
  • 3Completion of the merger remains subject to customary closing conditions and other required regulatory approvals.
  • 4Baker Hughes acknowledges the substantial indebtedness it expects to incur to finance the transaction.
  • 5The company highlights potential risks including integration challenges, achieving expected synergies, and competition.
  • 6Forward-looking statements are presented with caution, emphasizing that actual results may differ materially due to various risks and uncertainties.

Frequently Asked Questions

The most significant update is the expiration of the Hart-Scott-Rodino (HSR) Act waiting period, which is a critical antitrust regulatory approval required for the merger to proceed.

No, both Baker Hughes and Chart Industries continue to expect the merger to close in mid-year 2026. The expiration of the HSR waiting period is a positive step, but other conditions and approvals are still pending.

The completion of the merger is still subject to customary closing conditions and the receipt of other applicable regulatory approvals besides the HSR Act clearance. Baker Hughes also anticipates incurring substantial indebtedness for the transaction.

Baker Hughes highlights several risks, including the ability to successfully consummate the transaction, obtain all required regulatory approvals, manage the substantial debt burden, achieve expected synergies and operating efficiencies, and challenges associated with integrating Chart's operations. They also mention intense competition and general economic conditions.